June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

Hinova Pharmaceuticals raises $40M series B
Hinova Pharmaceuticals Inc (Chengdu, China) completed a $40 million series B round led by

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE